Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients with COVID-19: A rapid systematic review and meta-analysis.

Clin Cardiol · 2020 · PMC7436520 · PMID 32757246

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although we found use of ACEI/ARB was associated with the decreased risk of severe COVID‐19 in the overall analysis, this benefit did not reach statistical significance in the sensitive analysis (with excluding unadjusted studies).Furthermore, subgroup analysis showed the benefit was also not statistically significant either in the general population or in patients with hypertension.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.